Search research articles
Contact Us
Filters
Showing results (71-80 of 118) with videos related to
Page
of 12
Sort By:
Neuro-Oncology
|
September 20, 2013
New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials
Thierry Gorlia, Wenting Wu, Meihua Wang, et al.
The Lancet. Oncology
|
March 3, 2022
Code of practice needed for samples donated by trial participants
Robert Coleman, Arlene Chan, Carlos Barrios, et al.
The Lancet. Oncology
|
December 18, 2007
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3
Thierry Gorlia, Martin J van den Bent, Monika E Hegi, et al.
Neuro-Oncology
|
October 24, 2012
EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma
Enrico Franceschi, Roger Stupp, Martin J van den Bent, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2012
New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials
Thierry Gorlia, Roger Stupp, Alba A Brandes, et al.
Molecular Oncology
|
November 1, 2019
Towards a Cancer Mission in Horizon Europe
Anton Berns, Ulrik Ringborg, Alexander Eggermont, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 15, 2014
Defining dose-limiting toxicity for phase 1 trials of molecularly targeted agents: results of a DLT-TARGETT international survey
Xavier Paoletti, Christophe Le Tourneau, Jaap Verweij, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 7, 2026
Leveraging the potential of prospective registries for radiation oncology research: 5-year experience from the EORTC-ESTRO radiotherapy infrastructure for Europe (E<sup>2</sup>-RADIatE) project
Yolande Lievens, Damien C Weber, Nicolaus Andratschke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2006
Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial
René-Olivier Mirimanoff, Thierry Gorlia, Warren Mason, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 2015
Evidence-Based Diagnostic Algorithm for Glioma: Analysis of the Results of Pathology Panel Review and Molecular Parameters of EORTC 26951 and 26882 Trials
Johan M Kros, Karin Huizer, Aurelio Hernández-Laín, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 118) with videos related to
Sort By:
Page
of 12
Neuro-Oncology
|
September 20, 2013
New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials
Thierry Gorlia, Wenting Wu, Meihua Wang, et al.
The Lancet. Oncology
|
March 3, 2022
Code of practice needed for samples donated by trial participants
Robert Coleman, Arlene Chan, Carlos Barrios, et al.
The Lancet. Oncology
|
December 18, 2007
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3
Thierry Gorlia, Martin J van den Bent, Monika E Hegi, et al.
Neuro-Oncology
|
October 24, 2012
EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma
Enrico Franceschi, Roger Stupp, Martin J van den Bent, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2012
New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials
Thierry Gorlia, Roger Stupp, Alba A Brandes, et al.
Molecular Oncology
|
November 1, 2019
Towards a Cancer Mission in Horizon Europe
Anton Berns, Ulrik Ringborg, Alexander Eggermont, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 15, 2014
Defining dose-limiting toxicity for phase 1 trials of molecularly targeted agents: results of a DLT-TARGETT international survey
Xavier Paoletti, Christophe Le Tourneau, Jaap Verweij, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 7, 2026
Leveraging the potential of prospective registries for radiation oncology research: 5-year experience from the EORTC-ESTRO radiotherapy infrastructure for Europe (E<sup>2</sup>-RADIatE) project
Yolande Lievens, Damien C Weber, Nicolaus Andratschke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2006
Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial
René-Olivier Mirimanoff, Thierry Gorlia, Warren Mason, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 2015
Evidence-Based Diagnostic Algorithm for Glioma: Analysis of the Results of Pathology Panel Review and Molecular Parameters of EORTC 26951 and 26882 Trials
Johan M Kros, Karin Huizer, Aurelio Hernández-Laín, et al.
Page
of 12